Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Physiol.

Sec. Respiratory Physiology and Pathophysiology

Interrogating Pulmonary Diffusing Capacity in Long COVID: Insights from DLCO and DLNO Testing

Provisionally accepted
  • 1Mayo Clinic Arizona, Scottsdale, United States
  • 2Mayo Clinic Minnesota, Rochester, United States

The final, formatted version of the article will be published soon.

Abstract Introduction: The lingering respiratory effects of COVID-19, particularly in patients with Long COVID, remain poorly understood, prompting a comprehensive evaluation of lung function in this population. Methods: Simultaneous measurements of diffusion capacity of the lungs for carbon monoxide (DLCO) and nitric oxide (DLNO), chest computed tomography (CT), lung ultrasound and questionnaires were collected in 74 subjects. Participants were categorized into two groups: those that have no lingering symptoms (NS, n=37) and those still struggling with symptoms after initial infection, the disease known as Long COVID (LC, n=37). Results: DLCO and DLNO were significantly lower in the LC group compared to the NS group (LC vs. NS, DLCO: 25.94±7.65 vs. 21.71±6.35 ml/min/mmHg, p=0.009; DLNO: 148.5±35.6 vs. 126.6±32.2 ml/min/mmHg, p=0.006). Pulmonary capillary blood volume (Vc) was also significantly lower in the LC group (43.38±13.87, 70.79±17.77, p=0.003; LC vs. NS, respectively). Alveolar volume (VA) is significantly lower in the LC group (LC vs. NS, 5.06±1.17 v. 5.95±1.16, p=0.004). There was no significant difference between groups for surface area of the lungs available for gas exchange by resistance to gas transfer across the alveolar-capillary membrane (DM) between groups (LC vs. NS, 208.63±97.3, 223.0±93.47 ml/min/mmHg, p=0.54). These findings indicate that Vc is the driving factor of decreased DLCO. CT findings and lung ultrasound showed no differences between the two groups for lung fluid (p=0.525; p=0.298). Conclusion: These findings suggest that a lack of volume available for perfusion could be problematic for these patients and as such requires further investigation for clinical management of these patients.

Keywords: Long Covid, COVID, Diffusion capacities for CO and NO, Alveolar volume, Membrane conductance

Received: 14 Oct 2025; Accepted: 10 Nov 2025.

Copyright: © 2025 Parks, Johnson, Shea, Kim, Johnston, Carlson, Schwartz and Wheatley-Guy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jordan Kimberly Parks, parks.jordan@mayo.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.